Madrona Ventures Acquires Patents For Obesity Treatment

Madrona Ventures has acquired the Obesity treatment’s European patent and the pending American patent application.

Reportedly, the company will be starting the phase II double-blind placebo-controlled clinical trial in Finland. The trial will last for six months.

The safe and effective treatment is a proprietary patented pharmaceutical medicine-based behaviour program by David Sinclair, who has already designed a similar treatment program that has shown results in the treatment of alcoholism.

Dr. Sinclair has now refined this method to provide a precise treatment of eating disorders. The program weakens and removes unhealthy eating habits while simultaneously preserving and reinforcing healthy eating behaviours, exercising, and other calorie-burning activities.